Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Skin allograft for severe chronic GvHD

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Crocchiolo R, Nicolini FE, Sobh M, Ducastelle-Lepretre S, Labussiere H, Dubois V et al. Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donor. Bone Marrow Transplant 2011; 46: 1153–1155.

    Article  CAS  PubMed  Google Scholar 

  2. Prehn RT, Main JM . A comparison between heterozygous and homozygous skin homografts. J Natl Cancer Inst 1954; 15: 191–194.

    CAS  PubMed  Google Scholar 

  3. Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M . Haematopoietic chimera in man after allogeneic (homologous) bone-marrow transplantation. Br Med J 1963; 2: 1633–1635.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M, Devries MJ et al. Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects. Blood 1965; 25: 179–196.

    PubMed  Google Scholar 

  5. Knobler HY, Sagher U, Peled IJ, Wexler MR, Steiner D, Rubinstein N et al. Tolerance to donor-type skin in the recipient of a bone marrow allograft. Transplantation 1985; 40: 223–225.

    Article  CAS  PubMed  Google Scholar 

  6. De Kock J, Meuleman P, Raicevic G, Rodrigues RM, Branson S, Meganathan K et al. Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response. Stem Cells 2014; 32: 2215–2228.

    Article  CAS  PubMed  Google Scholar 

  7. Socié G, Ritz J . Current issues in chronic graft-versus-host disease. Blood 2014; 124: 374–384.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M . Adoptive immunotherapy of acute leukemia: experimental and clinical results. Cancer Res 1965; 25: 1525–1531.

    PubMed  Google Scholar 

  9. Tan AW, Koh LP, Goh BK . Leucoderma in graft-versus-host disease: excellent repigmentation with noncultured cellular grafting. Br J Dermatol 2011; 165: 435–437.

    Article  CAS  PubMed  Google Scholar 

  10. Milner SM, Cordova AC, Leffell M, Price LA . Cultured epithelial allograft for the management of cutaneous graft-versus-host disease following stem-cell transplantation. Transplantation 2011; 92: e53–e54.

    Article  PubMed  Google Scholar 

  11. Billingham RE, Brent L, Medawar PB . Actively acquired tolerance of foreign cells. Nature 1953; 172: 603–606.

    Article  CAS  PubMed  Google Scholar 

  12. Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST . Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance. Clin Pharmacol Ther 2013; 93: 36–45.

    Article  CAS  PubMed  Google Scholar 

  13. Ravindra KV, Wu S, McKinney M, Xu H, Ildstad ST . Composite tissue allotransplantation: current challenges. Transplant Proc 2009; 41: 3519–3528.

    Article  CAS  PubMed  Google Scholar 

  14. Filipovich AH, Weisdort D, Pavletic S, Socie G, Wingard JR, Lee SJ . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all personnel at the Department of Hematology of Lyon-Sud Hospital (Pierre Bénite, Lyon, France) and at the Department of Plastic Surgery of Croix Rousse Hospital (Lyon, France) for their remarkable contribution in patient’s care and assistance to her family.

Author contributions

RC conceived the treatment and wrote the manuscript; VD performed the chimerism analyses; F-EN, SD-L, HL, CA, AM, OD and FB provided clinical care; MS provided technical assistance; FC revised and commented on the manuscript; MM provided clinical care, followed the patient and supervised the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Crocchiolo.

Ethics declarations

Competing interests

RC is an employee of MolMed SpA at the time of submission. The remaining authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crocchiolo, R., Dubois, V., Nicolini, FE. et al. Skin allograft for severe chronic GvHD. Bone Marrow Transplant 52, 1060–1062 (2017). https://doi.org/10.1038/bmt.2017.53

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2017.53

Search

Quick links